221 related articles for article (PubMed ID: 2505395)
21. Bispecific monoclonal antibodies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA).
Bos R; Nieuwenhuizen W
Ann N Y Acad Sci; 1992 Dec; 667():428-30. PubMed ID: 1309066
[No Abstract] [Full Text] [Related]
22. Biological properties of recombinant and of natural pro-urokinase.
Gurewich V; Pannell R
Thromb Haemost; 1985 Aug; 54(2):558-9. PubMed ID: 3936220
[No Abstract] [Full Text] [Related]
23. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
[TBL] [Abstract][Full Text] [Related]
24. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
Gurewich V
Enzyme; 1988; 40(2-3):97-108. PubMed ID: 2971533
[TBL] [Abstract][Full Text] [Related]
25. Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
Pannell R; Li S; Gurewich V
J Thromb Thrombolysis; 2017 Aug; 44(2):210-215. PubMed ID: 28600623
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of plasminogen activators.
Weitz JI; Stewart RJ; Fredenburgh JC
Thromb Haemost; 1999 Aug; 82(2):974-82. PubMed ID: 10605812
[No Abstract] [Full Text] [Related]
27. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
28. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
Maksimenko AV
Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792
[TBL] [Abstract][Full Text] [Related]
29. The search for the ideal thrombolytic agent.
Verstraete M
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of action of newer thrombolytic agents.
Collen D
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
[TBL] [Abstract][Full Text] [Related]
32. Comparison of affinities of urokinase and tissue plasminogen activator for fibrin clots.
Homandberg GA; Wai T
Thromb Res; 1989 Aug; 55(4):493-501. PubMed ID: 2510355
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
34. [Tissue plasminogen activator].
Matsuo O
Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
[No Abstract] [Full Text] [Related]
35. Physiological consequences of loss of plasminogen activator gene function in mice.
Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of plasminogen activation by mammalian plasminogen activators.
Lijnen HR; Collen D
Enzyme; 1988; 40(2-3):90-6. PubMed ID: 3139404
[TBL] [Abstract][Full Text] [Related]
38. [Recent progress in fibrinolytic mechanism].
Yasukouchi T
Rinsho Byori; 1986 Mar; 34(3):235-46. PubMed ID: 3086600
[No Abstract] [Full Text] [Related]
39. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Trübestein G; Popov S; Wolf H; Welzel D
Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
[TBL] [Abstract][Full Text] [Related]
40. [New thrombolytic agents].
Nguyen G; Samama M
Ann Biol Clin (Paris); 1987; 45(2):212-8. PubMed ID: 3113300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
